In the complicated life sciences industry, Veeva Systems (NYSE: VEEV) has managed to create an all-in-one software solution where companies of all sizes can bring products to market faster and more efficiently while maintaining compliance. Its unique ecosystem of products allows drug developers to collect data and make decisions by having a streamlined process from research to commercialization. Veeva has promising growth drivers that could continue its trend of robust revenue growth — which could allow the business to prosper for the next 20 years.